Clinical trial
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range of 70 - 180 mg/dl Compared to SMBG
NCT06704672 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range of 70 - 180 mg/dl Compared to SMBG
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 14, 2025
- Completion date
- May 30, 2027
- Enrollment
- 270 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus, type 2 diabetes mellitus